Surface Modified Nanoparticulate Carriers for the Targeted Treatment of Breast Cancer

Neeraj Mishra, Tejinder Singh, Nidhi, Supandeep Singh Hallan, Veerpal Kaur

Research output: Contribution to journalReview articlepeer-review


Breast cancer left overs one of the greatest common metastasis disease in females. Advanced diagnostic devices and better understanding of tumour biology can extend the better therapeutic outcomes. Nanotechnology is a tool that helps in cancer diagnosis and treatment therapy. Many nanocarriers such as solid lipid nanoparticles, magnetic nanoparticles, nanocrystals, nanogels, nano-lipid nanocarriers, biodegradable nanoparticles, liposomes, and dendrimers are introduced to improve the therapeutic efficacy of antineoplastic agents. Surface modified target drug delivery system has the potential to increase the therapeutic effects and also reduce the cytotoxicity of breast cancer. Different approaches have been explored for treatment of breast cancer. This review describes the recent advances in the development of nanocarriers used for the targeted treatment of breast cancer. It also focuses on etiology, risk factor and conventional therapy of breast cancer.
Original languageEnglish
Pages (from-to)2698-2714
JournalInternational Journal of Pharmaceutical Sciences and Nanotechnology
Issue number1
Publication statusPublished - Feb 2015
Externally publishedYes

Field of Science*

  • 3.1 Basic medicine

Publication Type*

  • 1.4. Reviewed scientific article published in Latvia or abroad in a scientific journal with an editorial board (including university editions)


Dive into the research topics of 'Surface Modified Nanoparticulate Carriers for the Targeted Treatment of Breast Cancer'. Together they form a unique fingerprint.

Cite this